“Safety and efficacy, better than expected”… China plans free general vaccination
viewer
Sinoparm, a Chinese pharmaceutical company that developed a novel coronavirus infection (Corona 19) vaccine and received conditional approval from the Chinese authorities, claimed that its vaccine met the standards of the World Health Organization (WHO).
On the 1st, Yang Xiaomeme, chief researcher of China’s national vaccine project and CEO of Sinofarm, told the state-run Global Times that “sinofam vaccine has a prophylactic effect of 79.34%.” I said.
Yang said, “As a result of analyzing the data obtained so far in phase 3 clinical trials, the safety and efficacy of the vaccine is better than expected.” The reported side effects of the vaccine are also relatively mild due to pain, swelling, fever, muscle pain, and headache at the injection site Insisted.
Sinoparm explained that the test results are based on test data conducted in the United Arab Emirates (UAE). The synopam vaccine was approved in the UAE and Bahrain and was used urgently by about 1 million people, and no serious side effects have been reported, the Global Times said.
In China, it plans to vaccinate residents in 10 regions, including Jiangsu and Guangdong.
CEO Yang said, “The vaccine will be supplied to the Chinese market every year at 500 to 700 million doses (one dose).” Will be expanded to
Meanwhile, Chinese health officials have announced that a large amount of Chinese-made vaccines will be released soon, and the vaccine will be vaccinated to the public on the premise of free.
In fact, in Guangdong, Zhejiang and Shandong provinces, major high-risk groups were vaccinated free of charge, and some regions, such as Wuhan, provided the vaccine for 234 yuan (worth 40,000 won) per dose. Currently, in Beijing, the price of vaccination has fallen to 120-180 yuan (worth 20,000-30,000 won).
/ Reporter Kwak Yoon-ah [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >